Drela Katarzyna, Stanaszek Luiza, Nowakowski Adam, Kuczynska Zuzanna, Lukomska Barbara
NeuroRepair Department, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
Stem Cells Int. 2019 Mar 6;2019:7012692. doi: 10.1155/2019/7012692. eCollection 2019.
Mesenchymal stem cells (MSCs) are attractive candidates for cell-based tissue repair approaches. Hundreds of clinical trials using MSCs have been completed and many others are still being investigated. For most therapeutic applications, MSC propagation is often required. However, ex vivo culture condition is not fully physiological and may affect biological properties of MSCs including their regenerative potential. Moreover, both cell cryopreservation and labelling procedure prior to infusion may have the negative impact on their expected effect . The incidence of MSC transformation during culture should be also taken into consideration before using cells in stem cell therapy. In our review, we focused on different aspects of MSC propagation that might influence their regenerative properties of MSC. We also discussed the influence of different factors that might abolish MSC proliferation and differentiation as well as potential impact of stem cell senescence and aging. Despite of many positive therapeutic effects of MSC therapy, one has to be conscious about potential cell changes that could appear during manufacturing of MSCs.
间充质干细胞(MSCs)是基于细胞的组织修复方法中颇具吸引力的候选细胞。数百项使用MSCs的临床试验已经完成,还有许多其他试验仍在进行研究。对于大多数治疗应用而言,通常需要扩增MSCs。然而,体外培养条件并不完全符合生理状态,可能会影响MSCs的生物学特性,包括其再生潜力。此外,细胞冷冻保存和输注前的标记程序都可能对其预期效果产生负面影响。在将细胞用于干细胞治疗之前,还应考虑培养过程中MSCs转化的发生率。在我们的综述中,我们重点关注了MSCs扩增可能影响其再生特性的不同方面。我们还讨论了可能消除MSCs增殖和分化的不同因素的影响,以及干细胞衰老和老化的潜在影响。尽管MSCs治疗有许多积极的治疗效果,但必须意识到在MSCs制备过程中可能出现的潜在细胞变化。